Back to search
FDAFDA · Food and drugs·Recall number D-0177-2023

0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only, Nephron Pharmaceuticals Corporation, 4500 12th St. Extension, W. Columbia, SC 29172, NDC: 0487-4301-10, UPC 3 04874 30110 3.

Published February 1, 2023 · Recall initiated: January 12, 2023

Summary

FDA records drug Class II recall D-0177-2023, published February 1, 2023 and initiated January 12, 2023. Recalling firm: Nephron Sc Inc; Status: Terminated; Reported quantity: 378 bags; Lot: Lot: 271043, Exp. 03/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: potential for trace amounts of product carryover.

What to do

Voluntary: Firm initiated · Letter

Get an email if SODIUM CHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SODIUM CHLORIDE
Manufacturer
Nephron Sc Inc
Distributor
Nationwide in the USA
UPC
0304874301257
Lot
Lot: 271043, Exp. 03/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only, Nephron Pharmaceuticals Corporation, 4500 12th St. Extension, W. Columbia, SC 29172, NDC: 0487-4301-10, UPC 3 04874 30110 3. recalled?

Yes. FDA published recall D-0177-2023 on February 1, 2023. Reported hazard: CGMP Deviations: potential for trace amounts of product carryover.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SODIUM CHLORIDE. UPC: 0304874301257.